Latest Cash Flow News

A1 Investments & Resources Ltd reported a modest cash outflow for the December quarter while actively pursuing acquisition opportunities backed by secured funding. The company aims to finalize a deal soon, contingent on shareholder and regulatory approvals.

Vmoto reports a 33% decline in FY24 unit sales but maintains operational cash flow positivity and secures new joint ventures in Thailand and Mexico to bolster its electric mobility footprint.

Viridis Mining and Minerals has raised A$3.5 million through a placement to fund critical development milestones for its Colossus Rare Earth Element project, following a major resource upgrade.

Intelligent Monitoring Group has secured a $122.5 million debt facility with National Australia Bank, halving its interest rate and freeing up capital for growth. This refinancing marks a pivotal step in the company’s strategic expansion plans.

Nufarm Limited’s 2025 AGM revealed a resilient FY24 performance despite industry headwinds, with strong growth in omega-3 canola and strategic cost-saving initiatives setting the stage for future expansion.

Black Canyon Limited’s recent infill drilling at the KR2 Prospect confirms thick, high-grade manganese zones, underpinning a potential upgrade from Inferred to Indicated Mineral Resource status and promising improved project economics.

Nufarm’s 2025 AGM revealed a resilient FY24 performance despite industry headwinds, with strategic investments in omega-3 canola, biofuels, and cost-saving initiatives setting the stage for growth in FY25.

Aeris Environmental has updated its quarterly cash flow report, confirming ongoing operational cash outflows but expressing confidence in maintaining current cash flow levels while exploring new funding avenues.

Redivium Limited remains suspended from ASX trading following a failed entitlement offer and key director resignations, raising fresh doubts about its financial viability and governance.

Maas Group Holdings has announced a fresh on-market share buyback of up to 10% of its issued capital, signaling strong confidence in its financial health and future prospects.

Biotron Limited reported a robust net cash inflow of $1.095 million for the December 2024 quarter, driven largely by government grants, supporting its operational stability despite ongoing R&D expenses.

Medlab Clinical reports a near-empty cash balance and zero receipts in Q2 2025, while actively pursuing a business acquisition ahead of its ASX removal date.